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Background: To examine the impact of the revised diagnostic criteria for 
neurocognitive disorders (NCDs) in the Diagnostic and Statistical Manual of 
Mental Disorders (DSM)-5 on the prevalence estimates of dementia and mild 
cognitive impairment (MCI).  
Methods: Two independent nationwide community random samples: 755 
participants aged 65 years or older from the Nationwide Survey on Dementia 
Epidemiology in Korea (NaSDEK) 2012 and 6,818 participants aged 60 years or 
older from the community-based prospective elderly cohort named Korean 
Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD) were re-
diagnosed according to the DSM-5 criteria.  
Results: The estimated age-, gender-, education-, and urbanicity-standardized 
prevalences of major and mild NCDs (NaSDEK/KLOSCAD) were 8.35%/5.15% 
and 11.10%/15.99%, respectively, and those of dementia and MCI were 8.74%/ 




NCD was 0.988/0.969, and that for MCI and mild NCD was 0.151/0.210. 
Prevalence of dementia was not significantly changed according to any age, gender, 
and educational strata and that of MCI decreased significantly in all strata except 
the strata of those aged 75 years or older, females, and those with seven or more 
years of education.  
Conclusion: Diagnostic discrepancies between major/mild NCDs and dementia/ 
MCI, which have mainly been due to the operationalization of neuropsychological 
performance criteria, may decrease in prevalence with the introduction of DSM-5. 
Hierarchical application of each criterion may minimize subjects with diagnostic 
orphans, which are caused by mismatches between neuropsychological 
performance and the level of functional impairment when using DSM-5. 
……………………………………………………………………………………… 
Keywords: prevalence, DSM-5, dementia, mild cognitive impairment, major 
neurocognitive disorder, mild neurocognitive disorder, epidemiology 
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Epidemiological indices of dementia such as prevalence, incidence, and risk factors 
are considerably influenced by changes in the diagnostic criteria [1]. For example, 
the prevalence estimates of dementia according to the Diagnostic and Statistical 
Manual of Mental Disorders (DSM)-IV were much lower than those according to 
the DSM-III (13.7% versus 29.1%, respectively) [1] and slightly higher than those 
according to the DSM-III-R (9.6% versus 6.3%, respectively) [2].  
 The 5th version of DSM (DSM-5), which was released in 2013, introduced 
two new diagnostic categories: major neurocognitive disorder (NCD) and mild 
NCD. Conceptually major NCD replaced “dementia” in previous DSM versions. 
However, its diagnostic criteria in the DSM-5 were not similar to those of dementia 
in previous DSM versions [3-5]. DSM-5 did not require the presence of learning 
and memory impairments in diagnosing major NCD nor the presence of 
impairments in at least two domains [6], while it did require a substantial 
impairment in cognitive performance, preferably documented by standardized 
neuropsychological testing, in addition to subjective concerns of cognitive decline 
(Table 1, Appendix S1).  
Mild NCD newly introduced mild cognitive impairment (MCI) into DSM 
as a diagnostic category. Its diagnostic criteria were quite similar to those for MCI 
proposed by the International Working Group on MCI (IWG-MCI) [7], except that 
delirium or other mental disorders should be excluded to diagnose mild NCD in 
DSM-5. Although DSM-5 did not recommend a specific neurocognitive 
assessment for diagnosing major or mild NCD, it noted that deficits on any given 
test would be expected to be between 1 and 2 standard deviations (SDs) below the 
appropriate norm for a diagnosis of mild NCD, and 2 SDs or more below the 




Table 1. Comparison of diagnostic criteria: dementia vs. major neurocognitive 
disorder (NCD) 
Diagnostic criteria DSM-IV: Dementia DSM-5: major NCD 
Necessary cognitive 
domains of 
significant decline  





to be evaluated  
memory impairment, 
aphasia, apraxia, agnosia, 
disturbance in executive 
function: 5 domains 
complex attention, 
executive function, 
learning and memory, 
language, perceptual-




apraxia + agnosia 
 
perceptual-motor 
complex attention (new) 
social cognition (new) 
Necessary number 
of cognitive 
domains of decline 
two or more one or more (including 






not needed  needed (2 SD or more 
below the norm) 
Abbreviations: DSM, Diagnostic and Statistical Manual of Mental Disorders; SD, Standard 
Deviation 
 
Table 2. Comparison of diagnostic criteria: MCI vs. mild neurocognitive disorder 
(NCD) 
Diagnostic criteria IWG-MCI: MCI DSM-5: mild NCD 
Cognitive domains 
to be evaluated  
not suggested specifically  complex attention, 
executive function, 
learning and memory, 
language, perceptual-
motor, social cognition: 6 






needed (more than 1.5 SD 
below the norm) 
needed (between 1.0 and 
2.0 SD below the norm): 
newly introduced lower 
limit for differentiating 




did not affect the diagnosis  excluded when they 
explained cognitive deficits 
better 
Abbreviations: DSM, Diagnostic and Statistical Manual of Mental Disorders; IWG-MCI, 




Inevitably, these changes in both nomenclature and diagnostic criteria 
introduced in DSM-5 brought concerns about the comparability of the 
epidemiological estimates and clinical outcomes between major/mild NCD and 
dementia/MCI. The reduced numbers of impaired cognitive domains 
may increase, while the limited range of neuropsychological performance may 
reduce, the prevalence estimates of major NCD compared to those of dementia 
diagnosed according to DSM-IV diagnostic criteria. The exclusion of major mental 
disorders may reduce, while the limited range of neuropsychological performance 
may either increase or reduce the prevalence estimates of mild NCD compared to 
those of MCI diagnosed according to IWG-MCI diagnostic criteria.  
There have been three population-based studies that investigated the 
impact of DSM-5 on the prevalence estimates of dementia and/or MCI (Table 3). 
However, these studies were subject to several methodological limitations. First, 
none of them investigated the impact of each criterion on the prevalence estimates 
separately [8-10]. Second, two of them investigated the impact on the prevalence 
estimates of MCI/mild NCD only, even though the prevalence estimates of 
MCI/mild NCD and dementia/major NCD may influence each other [9, 10]. Third, 
two of them did not investigate the diagnostic orphans produced by the 
introduction of DSM-5 [8, 9]. Fourth, one of them did not describe how they 
operationalized each diagnostic criterion, and thus their results cannot be directly 
compared to the results of other studies [9]. 
 
Objectives 
This study aimed to investigate the impact of DSM-5 on the prevalence estimates 
of dementia and MCI simultaneously in two independent nationwide populations 
with the following hypotheses. (1) The reduction in the number of impaired 
cognitive domains for the diagnosis of major NCD, from two (including memory 
 
4 
function) to one (regardless of memory impairment), will increase the prevalence 
estimate of major NCD compared to that of dementia. (2) The increase in the 
number of cognitive domains to be evaluated for the diagnosis of major/mild NCD, 
from five to six, will increase the prevalence estimates of major NCD/mild NCD 
compared to those of dementia/MCI. (3) The addition of performance on 
standardized neuropsychological tests that is two or more SDs below age-, gender-, 
education-adjusted norms for the diagnosis of major NCD will decrease the 
prevalence estimate of major NCD compared to that of dementia. (4) The change in 
the performance of standardized neuropsychological tests for the diagnosis of mild 
NCD, from 1.5 SDs below the norm to 1-2 SD below the norm will increase the 
prevalence estimate of mild NCD compared to that of MCI, since the proportion 
below -1.5 SD corresponds to 6.7%, while -2.0 – -1.0 SD corresponds to 13.6% in 
a normal distribution. (5) The exclusion of major psychiatric disorder from mild 
NCD will decrease the prevalence estimate of mild NCD compared to that of MCI. 
(6) Based on hypotheses 1-3, the overall prevalence of major NCD will be 
decreased compared to that of dementia. Subjects with functional impairment 
corresponding to major NCD may already have cognitive concerns in at least two 
cognitive domains. The proportion of amnestic disorders or rare types of dementing 
illnesses may be low in community populations. Therefore, the decrease in 
prevalence by hypothesis 3 may surpass the increase by hypothesis 1 and 2. (7) 
Based on hypotheses 2, 4, and 5, the overall prevalence of mild NCD will be 
increased compared to that of MCI. Exclusion of major psychiatric disorder and the 
application of the lower limit of neuropsychological performance (2.0 SD below 
the norm) may decrease the prevalence of MCI. However, the increase in 
prevalence by hypotheses 2 and 4 may surpass the decrease by hypothesis 5. (8) 
Changes mentioned in hypotheses 1-7 will have different impacts on the 
prevalence rate according to demographic characteristics, such as age, gender, and 
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educational level. (9) There will be some cases that cannot be diagnosed as any 
NCD by DSM-5 because of the discrepancy between cognitive performance and 
the level of functional impairment, although they are diagnosed as MCI or 




Table 3. Previous research on the changes in prevalence produced by introduction 
of DSM-5 
 
Eramuduolla et al. 
[8] 
Lopez-Anton et al. 
[9] 
Luck et al. [10] 
Region Australia, Canberra 
(1 city), 2 Towns 
around Quebec  





























1,664 older people 
aged 72 to 78 who 
participated to 12 
years of follow-up 
(baseline age: 64-64 
years old)  
Random sampling 
(Stratified extraction 
according to age and 
gender census over 
55 years), 4,803 
subjects 
Random sampling 
(40-70 years old, 
stratified extraction 
according to age, 
gender), 1,180 older 
people aged 60 to 79 
(one excluded by 
dementia, 109 














IWG-MCI [7] vs. 
DSM-5 
Petersen MCI 
criteria [11] vs. 
DSM-5 









: MAC-Q >24 or 
IQCODE >3.31 or 
clinician’s 
judgement 
Dementia: mean Z 
score ≤ -2.0 SD for 
each domain (total 5 
cognitive domains), 
neuropsychological 
battery was different 
from that of major 
NCD 
Cognitive and ADL’s 
items in the 
ZARADEMP 
Interview, Geriatric 
Mental State (GMS) 



















MNCD: ≤ -2.0 SD 
mNCD/MCI: > -2.0 
to ≤ -1.0 
MNCD/mNCD/MCI
: using the same 
neuropsychological 
battery (6 cognitive 
domains) 
mNCD, social 
cognition tests were 







: not describe the 
detailed 
operationalization 
mNCD: -2 – -1 SD 




battery (6 cognitive 
domains including 









reported problem or 
Bayer IADL > 3.12 
mNCD/MCI: no 
problem or Bayer 
IADL < 3.12  
Lawton & Brody 




mNCD/MCI: ≤ 1 
impaired everyday 
activity on the 
SIDAM-ADL scale 









entia: PHQ-9 < 10 
and clinician’s 
judgement 






item, ≥ 23 on the 
CES-D, CIDI-
screening questions 
MCI: not excluded 
Study 
results  
No information of 
weighted prevalence  
Changes of 
diagnosis 
Dementia (n = 30) to 
MNCD (n = 68); 
127% increase 
MCI (n = 144) to 
mNCD (n = 171), 






MCI 7.93% to 
mNCD 3.72% 
decrease over 65 





MCI (n = 237) 
22.0% to mNCD (n 
= 222) 20.3% 
decrease 
MCI 19.5% to 
mNCD 20.3% 
increase (social 
cognition tests were 










impairment of only 
non-memory 
domains affecting 
functional level of 
dementia (n = 41), 
they may be non-AD 
dementia 
mNCD increase: 
newly diagnosed by 
impairment in social 
cognition (n = 52) 
mNCD decrease: 
more stringent 
criteria for the 
cognitive deficit in 
the mNCD and by 
the exclusion of 
psychiatric disorder  
mNCD decrease: 
exclusion of major 
psychiatric disorder  
mNCD increase 
(exclude social 
cognition for MCI): 
impairment of social 






Dementia to mNCD 
(n = 3) 
MCI to Diagnostic 
orphan (n = 25): 
they could not be 
diagnosed to any 
disorders in DSM-5 
Not mentioned  MCI with -2.0 SD of 
neuropsychological 
performance and 
functional level of 
non-dementia: 
diagnosed to mNCD 
(n = 30) 
Further mentioned 
the necessity of 
guideline for 




that of functional 
independence. 
MCI to Diagnostic 
orphan (n = 15) due 
to schizophrenia or 
severe depression  
Limitatio
ns of the 
study  
1. Small number of 
research centers 
2. Selection or 
survival bias: 
successful follow-up 
for 12 years 
3. No weighted 
prevalence 
4. Prevalence of 
specific age strata  
3 & 4: limited 
generalization 




1. only one region 
2. Small number of 
neuropsychological 
tests (n = 3) 
3. Prevalence change 
of dementia: not 
performed 
4. Not mentioned 
detailed 
operationalization of 
each criterion: the 
impact on the 
change by each 
criterion could not 
quantified.  
1. only one region 
2. Prevalence change 




in DSM-5 (MCI to 
diagnostic orphan)  
Abbreviations: AD, Alzheimer’s disease; ADL, Activities of Daily Living; DSM, 
Diagnostic and Statistical Manual of Mental Disorders; GMS, Geriatric Mental State; IADL, 
Instrumental ADL; IQCODE, Informant Questionnaire of Cognitive Decline in the Elderly 
16-item Short Version; IWG-MCI, International Working Group on MCI; MAC-Q, 
Memory and Cognition Questionnaire; MCI, Mild Cognitive Impairment; MNCD, Major 
neurocognitive disorder; mNCD, mild neurocognitive disorder; NCD, neurocognitive 
disorder; PHQ-9, Patient Health Questionnaire; SD, Standard Deviation; SIDAM, 
Structured Interview for Diagnosis of Dementia of Alzheimer type, Multi-infarct Dementia 





This study was conducted on two independent nationwide elderly populations: the 
second Nationwide Survey on Dementia Epidemiology of Korea (NaSDEK) [12] 
and the baseline assessment of the Korean Longitudinal Study on Cognitive Aging 
and Dementia (KLOSCAD) [13]. In the NaSDEK, which adopted a 2-phase design 
(screening phase and diagnostic phase), 755 participants aged 65 years or older 
completed the diagnostic phase that included clinical and neuropsychological 
assessments. In the KLOSCAD, which adopted a 1-phase design, 6,818 
participants aged 60 years or older completed clinical and neuropsychological 
assessments (Table 4). Owing to the limited sample size, we tested hypotheses 1, 2, 
3, 4, 5, and 8 in the KLOSCAD only. 
 
Table 4. Characteristics of the study populations 
Study NaSDEK [12] KLOSCAD [13] 
Period Mar 2012 - Dec 2012  Nov 2010 - Oct 2012 
Design two-phase (screening & 
diagnostic) 
Cross-sectional study 
Single-phase (diagnostic)  
Prospective longitudinal study 
Sample   
 Sampling Stratified random sampling 
from 24 villages and towns 
from 16 districts across South 
Korea 
Stratified random sampling 
from 30 villages and towns 
from 13 districts across South 
Korea 
 Size 6,008 12,496 
 Responders 4,016 in screening phase 
(67.0%) 
755 in diagnostic phase 
(69.0%) 
6,818 (53.7%) 
 Age 65 years or older 60 years or older 
 Area Mixed (urban and rural) Mixed (urban and rural) 
Study centers 14 university hospitals and 
three geriatric hospitals 
12 university hospitals and 
one geriatric hospital 
Assessments  CERAD-K-C [14], CERAD-
K-N [14, 15], DST [16], FAB 
[17], laboratory tests 
(dementia only), brain 
imaging (dementia only) 
CERAD-K-C [14], CERAD-
K-N [14, 15], DST [16], FAB 
[17], laboratory tests, brain 
imaging (dementia only) 
Abbreviations: CERAD-K-C, Korean version of the Consortium to Establish a Registry for 
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Alzheimer’s Disease Assessment Packet (CERAD-K) Clinical Assessment Battery; 
CERAD-K-N, CERAD-K Neuropsychological Assessment Battery; DST, Digit Span Test; 
FAB, frontal assessment battery; KLOSCAD, Korean Longitudinal Study on Cognitive 
Aging and Dementia; MMSE, Mini-Mental State Examination; NaSDEK, Nationwide 
Survey on Dementia Epidemiology in Korea; SGDS, Short Geriatric Depression Scale 
 
Subjects (Table 5) 
The NaSDEK is a multi-center, population-based, cross-sectional epidemiologic 
survey conducted in 2012. This study was conducted by 17 research centers (three 
in Seoul, four in Gyeonggi-do, one in Gangwon-do, two in Chungcheongnam-do, 
one in Chungcheongbuk-do, one in Jeollabuk-do, two in Gyeongsangbuk-do, two 
in Gyeongsangnam-do, and one in Jeju-do) and steered by the Seoul National 
University Bundang Hospital (SNUBH). The NaSDEK employed a two-stage 
design to estimate the prevalence of major NCD, mild NCD, dementia, and MCI. 
In the NaSDEK, 6,008 Koreans aged 65 years or older were randomly sampled 
from the residents of 24 villages and towns from 16 districts across South Korea, 
and invited to the Phase I screening assessment using the Korean version of the 
Mini-Mental State Examination (MMSE) [18]. Among them, 4,016 responded to 
the Phase I assessment (response rate = 67%), and were assigned to one of three 
groups according to their MMSE performance using the age-, gender-, and 
education-adjusted norm for elderly Koreans [17]; poor (MMSE score less than -
1.5 SD from the norm), intermediate (MMSE score between -1.5 and -1.0 SD from 
the norm), and good (MMSE score of -1.0 SD or higher from the norm). Then, 
1,097 participants (318 from the good performance group, 149 from the 
intermediate performance group, and 639 from the poor performance group) who 
were randomly sampled from each group with different group-specific sampling 
fractions (10% from the good performance group, 50% from the intermediate 
performance group, and 100% from the poor performance group), were invited to 
the Phase II diagnostic assessment. Among them, 755 (response rate in the good 
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performance group = 71%, response rate in the intermediate performance group = 
77%, response rate in the poor performance group = 66%; p = 0.025) completed 
the Phase II diagnostic assessment (Table 5).  
The KLOSCAD is a multi-center, population-based, prospective elderly 
cohort study launched in 2009. This study has been conducted by 13 research 
centers (three in Seoul, three in Gyeonggi-do, one in Gangwon-do, two in 
Chungcheongnam-do, one in Chungcheongbuk-do, one in Gyeongsangbuk-do, one 
in Gyeongsangnam-do, and one in Jeju-do) and steered by the SNUBH. In the 
KLOSCAD, 12,496 Koreans aged 60 years or older were randomly sampled from 
the residents of 30 villages and towns from 13 districts across South Korea, and 
6,818 (53.7%) completed the baseline diagnostic assessment of KLOSCAD. All 
participants were fully informed of the study protocol, and provided written 
informed consent, signed by the subjects or their legal guardians. The Institutional 
Review Board of SNUBH (no. B-1204/149-001 for NaSDEK, no. B-0912/089-010 














Table 5. Sociodemographic and clinical characteristics of the study populations 
 NaSDEK [12] KLOSCAD [13] P value 
Participants, number 755 6,818  
Age, years (mean ± SD) 76.05 ± 7.29 70.50 ± 7.10 < 0.001 
Women, number (%) 474 (62.8) 3,919 (57.5) 0.005 
Education, years (mean ± SD) 6.03 ± 5.60 7.83 ± 5.38 < 0.001 
Illiteracy in reading, number (%) 139 (18.4) 275 (4.0) < 0.001 
Illiteracy in writing, number (%) 145 (19.2) 323 (4.7) < 0.001 
Current occupation, number (%) 159 (21.1) 2,035 (29.8) < 0.001 
Urban residence (%) 480 (63.6) 4,851 (71.7) < 0.001 
Marital status, number (%)    
Married 434 (57.5) 4,697 (68.9) < 0.001 
Bereaved 290 (38.4) 1,789 (26.2)  
Divorced, separated, 
unmarried 
31 (4.1) 332 (4.9)  
Cohabitants, number (%)   < 0.001 
None 138 (18.3) 1,000 (14.7)  
Family 555 (74) 5,673 (83.2)  
Others 5 (0.7) 145 (2.13)  
Institutionalized 57 (7.5) -  
Short Geriatric Depression Scale 5.79 ± 4.20  4.80 ± 3.68 < 0.001 
Mini-mental State Examination 20.25 ± 6.60 25.17 ± 4.32 < 0.001 
Abbreviations: KLOSCAD, Korean Longitudinal Study on Cognitive Aging and Dementia; 
NaSDEK, Nationwide Survey on Dementia Epidemiology in Korea; SD, standard deviation 
 
Diagnostic assessments  
In the Phase II diagnostic assessment of NaSDEK and the baseline diagnostic 
assessment of the KLOSCAD, geriatric psychiatrists with expertise in dementia 
research administered a face-to-face standardized diagnostic interview, and 
physical and neurological examinations to each subject using the Korean version of 
the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet 
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(CERAD-K) Clinical Assessment Battery (CERAD-K-C) [14]. A research 
neuropsychologist or trained research nurse administered the CERAD-K 
Neuropsychological Assessment Battery (CERAD-K-N) [14, 15], Digit Span Test 
(DST) [16], and frontal assessment battery [17] to each subject. Geriatric 
psychiatrists evaluated comorbid mental disorders, including depressive disorders, 
using the Korean version of the Mini International Neuropsychiatric Interview 
(MINI-K) [19, 20]. Computed tomography or magnetic resonance imaging (T1-
weighted, T2-weighted, and fluid attenuated inversion recovery [FLAIR]) of the 
brain; laboratory tests, including complete blood cell counts, chemistry profiles, 
and a serological test for syphilis; echocardiography; and chest X-rays were 
conducted for each subject diagnosed with dementia to determine the subtype. 
Dementia and major NCD were diagnosed according to the DSM-IV [4] 
and DSM-5 diagnostic criteria [21], respectively (Table 6). For a diagnosis of 
dementia, subjects had to exhibit memory impairment and one or more of four 
other cognitive disturbances (aphasia, apraxia, agnosia, and disturbance in 
executive functioning) that were severe enough to cause significant impairment in 
social or occupational functioning and to show significant decline from a previous 
level of functioning. Research geropsychiatrists determined the presence of 
functional impairment by clinical judgment and confirmed them by case 
conferences. We excluded major psychiatric disorder that better explained the 
cognitive deficits using clinicians’ diagnosis of psychiatric disorders.  
In contrast to the diagnosis of dementia, major NCD could be diagnosed if 
the subject showed evidence of cognitive decline in one or more of six cognitive 
domains (complex attention, executive function, learning and memory, language, 
perceptual-motor, or social cognition). The presence of cognitive concern in each 
domain except complex attention in DSM-5 was determined according to the 
previously coded information by research geropsychiatrists who directly evaluated 
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the participants using DSM-IV (i.e., positive cognitive concern or negative 
cognitive concern). To determine the presence of cognitive concern regarding 
complex attention, the author reviewed the previously acquired text information of 
cognitive concern and coded the presence of cognitive decline in complex attention. 
The presence of a substantial impairment in cognitive performance was ascertained 
by performance in one or more neuropsychological tests 2.0 SD or below the age-, 
gender-, and education-adjusted norm of elderly Koreans [15] as noted in the 
DSM-5. The threshold for impaired functional activities required for a diagnosis of 
major NCD was set at the same level as that for dementia, except in the case that 
the severity of functional decline that interferes with independence in everyday 
activities was indeterminate between the functional level of MCI and dementia. In 
that case, we classified the level of functional impairment to the level of MCI when 
using the IWG-MCI/DSM-IV system, but we did classify the level of functional 
impairment to the level of major NCD when using the DSM-5 system.  
MCI and mild NCD were diagnosed according to the consensus criteria 
proposed by the IWG-MCI [22] and the DSM-5 diagnostic criteria [21], 
respectively (Table 6). Clinicians confirmed cognitive concern on the basis of 
careful history taking containing questioning about specific symptoms that 
commonly occur in individuals with cognitive deficits referring to self and/or 
informant reporting of cognitive decline [15]. The presence of objective cognitive 
impairment was ascertained by performance in one or more neuropsychological 
tests more than 1.5 SD below the age-, gender-, and education-adjusted norm of 
elderly Koreans [15]. We also applied more than 1.0 SD below the norm to 
maintain maximal consistency in the application of the criterion for objective 
impairment between the IWG-MCI and the DSM-5 in the NaSDEK. For a 
diagnosis of MCI, basic activities of daily living needed to be preserved, and 




Similar to the criteria for major NCD, mild NCD also required evidence of 
cognitive decline in one or more of the six cognitive domains. However, the 
presence of a substantial impairment in cognitive performance was ascertained by 
performance in one or more neuropsychological tests within -2.0 to -1.0 SD of the 
age-, gender-, and education-adjusted norm of elderly Koreans as noted in the 
DSM-5 [23]. The threshold for impaired functional activities required for a 
diagnosis of mild NCD was set at the same level as that for MCI, except in the case 
that the severity of functional decline that interferes with independence in everyday 
activities was indeterminate between the functional level of MCI and dementia. In 
that case, we classified the level of functional impairment to the level of MCI when 
using IWG-MCI/DSM-IV system, but we did classify the level of functional 
impairment to the level of major NCD when using the DSM-5 system. We 
excluded major psychiatric disorder that better explained the cognitive deficits 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































We compared the sociodemographic and clinical characteristics of the NaSDEK 
and KLOSCAD using an independent t-test for continuous variables and a chi-
square test for categorical variables. For estimating prevalence of dementia, major 
NCD, MCI, and mild NCD, we used sample weights based on the distribution of 
age (60-64 years old; 65-69; 70-74; 75-79; 80-84; 85 or older), gender, educational 
level (0 years, 1-6 years, 7 or more years), and urbanicity (urban, rural) from the 
2010 National Census data. In the NaSDEK sample, we used additional sample 
weights considering the sampling fractions of and response rates to Phase II 
diagnostic assessment. We examined the significance in the change of prevalence 
of dementia and MCI using paired t-tests and examined the diagnostic agreement 
between dementia and major NCD; for MCI and mild NCD, we used Cohen’s 
kappa measure of agreement. To estimate the prevalence, we employed the PROC 
SURVEYFREQ tool in SAS version 9.3 (SAS Institute, Cary, NC), which applied 
Taylor’s series expansion to estimate standard errors and confidence intervals (CIs). 
We conducted the other analyses using Statistical Package for the Social Sciences 
software, Release Version 22.0 (SPSS for Windows Inc., Chicago, Illinois). Two-







Prevalence estimates for dementia and major NCD (Tables 7 and 8) 
In the NaSDEK sample, 505 out of 755 had cognitive concerns in one or more 
cognitive domains (DSM-5 A1 criterion) and 347 had concerns in two or more 
cognitive domains including memory (DSM-IV A criterion), indicating that the 
likelihood to satisfy the DSM-5 A1 criterion may be about 1.5 times higher than 
that to satisfy the DSM-IV A criterion. However, among the 505 participants who 
met the DSM-5 A1 criterion, only 388 (76.8%) had a neuropsychological 
performance of 2.0 SD or more below the age-, gender-, and education-adjusted 
norm, and thus satisfied the DSM-5 A2 criterion. Therefore, the likelihood to 
satisfy both the DSM-5 A1 and A2 criteria may be about 1.1 times higher than that 
to satisfy the DSM-IV A criterion. 
Among the 388 participants who met both DSM-5 A1 and A2 criteria, 158 
were functionally impaired enough to lose their independence in everyday 
activities and satisfied the DSM-5 B criterion. Among the 347 participants who 
met the DSM-IV A criterion, 161 were functionally impaired to a degree that 
caused significant impairment in social or occupational functioning and satisfied 
the DSM-IV B criterion, indicating that the likelihood to satisfy the DSM-5 A and 
B criteria may be comparable to that to satisfy the DSM-IV A and B criteria. 
After excluding six participants who were better explained by delirium or 
major depressive disorder, 152 were diagnosed with major NCD according to 
DSM-5 diagnostic criteria and 155 were diagnosed with dementia according to the 
DSM-IV diagnostic criteria. The age-, gender-, education-, and urbanicity- 
standardized prevalences among Korean individuals aged 65 years or older was 
estimated to be 8.35% (95% CI = 6.39 – 10.31) for major NCD and 8.74% (95% CI 
= 6.70 – 10.78) for dementia; the difference between these two estimates were not 
statistically significant (p = 0.898) and Cohen’s kappa between dementia and major 
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NCD was 0.988. 
In the KLOSCAD sample, 3,356 out of 6,818 had cognitive concerns in 
one or more cognitive domains (DSM-5 A1 criterion) and 1,053 had concerns in 
two or more cognitive domains including memory (DSM-IV A criterion), 
indicating that the likelihood to satisfy the DSM-5 A1 criterion may be about 3.2 
times higher than that to satisfy the DSM-IV A criterion. However, among the 
3,356 participants who met the DSM-5 A1 criterion, only 1,614 (48.1%) had a 
neuropsychological performance of 2.0 SD or more below the age-, gender-, and 
education-adjusted norm and thus satisfied the DSM-5 A2 criterion. Therefore, the 
likelihood to satisfy both the DSM-5 A1 and A2 criteria may be about 1.5 times 
higher than that to satisfy the DSM-IV A criterion. 
Among the 1,614 participants who met both DSM-5 A1 and A2 criteria, 
339 were functionally impaired enough to lose their independence in everyday 
activities and satisfied the DSM-5 B criterion. Among the 1,053 participants who 
met the DSM-IV A criterion, 348 were functionally impaired to a degree that 
caused significant impairment in social or occupational functioning and satisfied 
the DSM-IV B criterion, indicating that the likelihood to satisfy the DSM-5 A and 
B criteria may be comparable to that to satisfy the DSM-IV A and B criteria. 
After excluding six participants who were better explained by delirium or 
major depressive disorder, 333 were diagnosed as major NCD according to DSM-5 
diagnostic criteria and 343 were diagnosed as dementia according to the DSM-IV 
diagnostic criteria after excluding five participants. The age-, gender-, education-, 
and urbanicity- standardized prevalences among Korean individuals aged 60 years 
or older was estimated to be 5.15% (95% CI = 4.60 – 5.70) for major NCD and 
5.32% (95% CI = 4.76 – 5.88) for dementia; the difference between these two 
estimates were not statistically significant (p = 0.552) and Cohen’s kappa between 
dementia and major NCD was 0.969. 
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When we analyzed each criterion separately in the KLOSCAD sample, 
none of the criterion changes introduced in DSM-5 produced statistically 
significant differences between the prevalence estimate of major NCD according to 
DSM-5 and that of dementia according to DSM-IV (Table 8), which was the case 
in all age, gender, and education strata (Table 9). In conclusion, the prevalence 
estimate of major NCD according to DSM-5 was found to be comparable to that of 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Prevalence estimates for MCI and mild NCD (Tables 10 and 11) 
In the NaSDEK sample, 505 out of 755 had cognitive concerns in one or more 
cognitive domains (DSM-5 and IWG-MCI A1 criterion), 78 (15.4%) had a 
neuropsychological performance within -2.0 to -1.0 SD of the age-, gender-, and 
education-adjusted norm (DSM-5 A2 criterion). Among the 78 subjects who met 
the A1 and A2 diagnostic criteria, 75 subjects did not have impairment that 
interfered with their capacity for independence in everyday activities (DSM-5 B 
criterion). Among the 441 participants who met the IWG-MCI A1 and A2 
diagnostic criteria, 281 had preserved or minimally impaired functional abilities 
and satisfied the IWG-MCI B criterion, indicating that the likelihood to satisfy the 
DSM-5 A and B criteria may be about 0.3 times lower than that to satisfy the IWG-
MCI A and B criteria.  
After the exclusion of two subjects who were better explained by delirium 
or major depressive disorder, 73 were diagnosed as mild NCD according to DSM-5 
diagnostic criteria and 281 who met the IWG-MCI A and B criteria were diagnosed 
as MCI according to the IWG-MCI diagnostic criteria. The age-, gender-, 
education-, and urbanicity- standardized prevalences among Korean individuals 
aged 65 years or older was estimated to be 11.10% (95% CI = 7.74–14.46) for mild 
NCD and 27.18% (95% CI = 22.79–31.56) for MCI; the difference between these 
two estimates was statistically significant (p < 0.001) and Cohen’s kappa between 
mild NCD and MCI was 0.151.  
In the KLOSCAD sample, 3,356 out of 6,818 had cognitive concerns in 
one or more cognitive domains among five domains (DSM-5 A1 criterion) and 
3,346 had cognitive concerns in one or more cognitive domains among six domains 
(IWG-MCI A1 criterion), indicating that the likelihood to satisfy the DSM-5 A1 
criterion may be comparable to that to satisfy the IWG-MCI A1 criterion. Among 
the 3,356 participants who met the DSM-5 A1 criterion, only 1,156 (34.4%) had a 
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neuropsychological performance within -2.0 to -1.0 SD of the age-, gender-, and 
education-adjusted norm and thus satisfy the DSM-5 A2 criterion. On the contrary, 
among the 3,346 participants who met the IWG-MCI A1 criterion, 2,184 (65.3%) 
had a neuropsychological performance below -1.5 SD from the norm and thus 
satisfied the IWG-MCI A2 criterion. Therefore, the likelihood to satisfy both the 
DSM-5 A1 and A2 criteria may be about 0.53 times lower than that to satisfy the 
IWG-MCI A1 and A2 criteria. 
Among the 1,156 participants who met both DSM-5 A1 and A2 criteria, 
1,139 did not have impairment that interferes with their capacity for independence 
in everyday activities (DSM-5 B criterion). Among the 2,184 participants who met 
the IWG-MCI A1 and A2 diagnostic criteria, 1,838 had preserved or minimally 
impaired functional abilities and satisfied the IWG-MCI B criterion, indicating that 
the likelihood to satisfy the DSM-5 A and B criteria may be about 0.62 times lower 
than that to satisfy the IWG-MCI A and B criteria.  
After excluding 35 participants who were better explained by delirium or 
major depressive disorder, 1,104 were diagnosed as mild NCD according to DSM-
5 diagnostic criteria and 1,838 who met the IWG-MCI A and B criteria were 
diagnosed as MCI according to the IWG-MCI diagnostic criteria. The age-, gender-, 
education-, and urbanicity- standardized prevalences among Korean individuals 
aged 60 years or older was estimated to be 15.99% (15.10–16.88) for mild NCD 
and 26.64% (25.55–27.72) for MCI; the difference between these two estimates 
were statistically significant (p < 0.001) and Cohen’s kappa between mild NCD 
and MCI was 0.210. 
When we analyzed each criterion separately in the KLOSCAD sample, the 
change in criterion for the neuropsychological performance introduced in DSM-5 
produced statistically significant differences between the prevalence estimate of 
mild NCD according to DSM-5 and that of MCI according to the IWG-MCI (Table 
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11), which was the case in all age, gender, and education strata except the strata of 
education ≥ 7 years, female, age ≥ 75 years old (Table 12). In conclusion, the 
prevalence estimate of mild NCD according to DSM-5 was found to be 



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































In NaSDEK and KLOSCAD, there were three and fifteen discrepant subjects, 
respectively, who were diagnosed with dementia according to the DSM-IV 
diagnostic criteria but not diagnosed with major NCD according to the DSM-5 
diagnostic criteria. They could not be diagnosed with any NCDs (diagnostic 
orphans) in the DSM-5 diagnostic classification, since their neuropsychological 
performances were better than 2.0 SD below the standard norms; however, their 
functional impairments were severe enough for them to lose their independence in 
everyday activities (B in NaSDEK and KLOSCAD, Figure 1). On the contrary, 
five subjects who were diagnosed with MCI according to the IWG-MCI diagnostic 
criteria changed their diagnosis to major NCD in KLOSCAD (Figure 1). They 
could not be diagnosed with dementia because of the number of cognitive concerns 
being only one (three subjects with memory impairment, two subjects with 
executive dysfunction), with indeterminate functional impairment between MCI 
and dementia using the DSM-IV/IWG-MCI diagnostic system. Using the DSM-5 
diagnostic system, they could be classified as having major NCD because of 
interference with capacity for independence in everyday activities. 
In the NaSDEK, among the 281 subjects who were diagnosed with MCI 
according to the IWG-MCI diagnostic criteria, 231 (82.2%) were not diagnosed 
with mild NCD according to the DSM-5 diagnostic criteria. Among them, nine 
(3.9%) were better explained by other mental disorders (major depressive disorder 
or delirium) while 222 (96.1%) were considered diagnostic orphans in the DSM-5 
diagnostic classification, since their neuropsychological performances were 2.0 or 
more SD worse than the standard norms but their cognitive impairment did not 
interfere with their capacity for independence in everyday activities ((A) in 
NaSDEK, Figure 1). In the KLOSCAD, among the 1,838 subjects who were 
diagnosed with MCI according to the IWG diagnostic criteria, 1,294 (70.4%) were 
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not diagnosed with mild NCD according to the DSM-5 diagnostic criteria. Among 
them, five (0.4%) subjects were diagnosed with major NCD, as mentioned above. 
Two subjects (0.2%) lost the diagnosis of MCI because they had indeterminate 
functional impairment between MCI and dementia but were judged to have some 
interference with independent functional ability ((A1) in KLOSCAD, Figure 1). 
Fifty-six (4.3%) subjects were better explained by major depressive disorder or 
schizophrenia, while 1,231 (95.1%) were considered diagnostic orphans in the 
DSM-5 diagnostic classification, since their neuropsychological performances were 
2.0 or more SD or worse than the standard norms but their cognitive impairment 
did not interfere with their capacity for independence in everyday activities ((A) in 
KLOSCAD, Figure 1). In conclusion, the introduction of DSM-5 produced 
diagnostic orphans because of the discrepancy between cognitive performance and 
the level of functional impairment in both samples. The diagnostic orphans in (A) 
in KLOSCAD showed a higher conversion rate to dementia (by DSM-IV) or major 
NCD (by DSM-5) than the subjects with mild NCD at baseline for the six years of 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 13. Comparison of clinicodemographic characteristics and conversion rates 
to dementia between diagnostic orphans and subjects with mild neurocognitive 
disorder (NCD) in the KLOSCAD sample 
 
Diagnostic 
orphan (A) in 
Figure 1 
mild NCD p value* 
Total number 1,231 1,104 
 
Baseline    
  Age, years (mean ± SD) 72.73 ± 7.17 70.33 ± 6.53 <0.001 
  Women, number (%) 751 (61.0%) 648 (58.7%) 0.255 
  Education, years (mean ± SD) 6.28 ± 4.99 7.75 ± 5.07 <0.001 
  Clinical Dementia Rating,  
  Sum of Boxes (mean ± SD) 
0.73 ± 0.65 0.51 ± 0.49 <0.001 
  Short Geriatric Depression     
  Scale (mean ± SD) 
5.74 ± 3.64 5.30 ± 3.57 0.004 
  Mini-mental State 
  Examination (mean ± SD) 
23.30 ± 4.25 25.53 ± 3.01 <0.001 
    
Two-year follow-up (n) 883  862  
 
  Major NCD, number (%) 52 (5.9%) 16 (1.9%) <0.001 
  Dementia, number (%) 55 (6.2%) 18 (2.1%) <0.001 
    
Four-year follow-up (n) 707 713 
 
  Major NCD, number (%) 92 (13.0%) 28 (3.9%) <0.001 
  Dementia, number (%) 99 (14.0%) 32 (4.5%) <0.001 
    
Six-year follow-up (n)   
 
  Major NCD, number (%) 123 (20.5%) 42 (7.1%) <0.001 
  Dementia, number (%) 125 (20.8%) 45 (7.6%) <0.001 
*p value for Chi-square test (categorical variables) or student’s t-test (continuous 
variables) 




We estimated the prevalence of major NCD and mild NCD and compared them 
with those of MCI and dementia in two independent nationwide populations in 
Korea. The prevalence estimate of major NCD according to the DSM-5 diagnostic 
criteria (8.35% in NaSDEK, 5.15% in KLOSCAD) was quite comparable to that of 
dementia according to the DSM-IV diagnostic criteria (8.74% in NaSDEK, 5.32% 
in KLOSCAD; Table 7), whereas the prevalence estimate of mild NCD according 
to the DSM-5 diagnostic criteria (11.10% in NaSDEK, 15.99% in KLOSCAD) was 
significantly lower than that of MCI according to the IWG diagnostic criteria 
(27.18% in NaSDEK, 26.64% in KLOSCAD; Table 10). These results indicate that 
the introduction of the DSM-5 may have differentially influenced the prevalence 
estimates of dementia and MCI.  
 
Prevalence estimates for dementia and major NCD  
In the NaSDEK, there were no subjects who were significantly impaired in only 
one cognitive domain or impaired in two or more cognitive domains with preserved 
learning and memory among those who had functional impairments with sufficient 
severity to lose their independence in everyday activities. In the KLOSCAD, five 
subjects who were significantly impaired in only one cognitive domain (3 subjects 
with memory impairment, 2 subjects with executive dysfunction) with functional 
impairment of sufficient severity to lose their independence in everyday activities 
were newly diagnosed as major NCD (Figure 1). There were no or few subjects 
with cognitive impairment in only one domain sufficient to bother the independent 
daily activities in both samples since amnestic disorders and/or rare types of 
dementing illnesses are less prevalent in randomly sampled community populations 
than in clinical populations. No adequate studies have been conducted on the 
prevalence estimates of amnestic disorders [24]. The prevalence estimates of 
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dementia with Lewy bodies/Parkinson’s disease and frontotemporal dementia were 
0.11% (95% CI = 0.00–0.23) and 0.03% (95% CI = 0.00–0.08), respectively, in a 
representative nationwide community sample of Koreans aged 65 years or older 
[25]. On the other hand, a previous study performed in a memory clinic reported 
that about 19% of patients with MCI were reclassified as having major NCD 
because of the presence of impairment in only a single cognitive domain and a lack 
of memory impairment in 30% of patients [26]. We may question whether 
cognitive impairment in only one domain that has sufficient severity to cause the 
loss of independence in everyday activities is possible in real. In cases of the very-
early phase of Alzheimer’s dementia (AD), memory impairment is related to 
executive function [27]. In cases of non-AD, for example, major frontotemporal 
NCD, cognitive concerns regarding complex attention, executive function, and 
social cognition can be presented simultaneously, even in the early-phase.  
The DSM-5 notes that a neuropsychological performance two or more SDs 
below the appropriate norm is a typical cutoff for ascertaining the presence of 
cognitive impairment [21]. Although this criterion has resulted in a minimal 
decrease without statistical significance in prevalence estimates of major NCD 
compared to that of dementia (Table 8, 9), the occurrence of diagnostic orphans 
due to the criterion for neuropsychological performance may be inevitable ((B) in 
Figure 1). 
 
Prevalence estimates for MCI and mild NCD  
In the NaSDEK, no subjects were newly defined to have cognitive concern 
according to the increase in the number of cognitive domains to be evaluated from 
five to six. In the KLOSCAD, 10 subjects were newly defined to have cognitive 
concern in the complex attention domain. The addition of the social cognition 
domain to be evaluated for diagnosing NCDs did not make any change because 
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subjects with impairment in social cognition also showed disturbances in executive 
function. As a result, an increased number of cognitive domains to be evaluated did 
not significantly affect the change in prevalence (Table 11).  
With respect to MCI, impairments on neurocognitive testing have usually 
been defined as performance below 1.5 SD of the age-, gender-, and education-
adjusted normative mean in a standardized test [28]. Recent attempts at early 
detection of at-risk individuals for dementia have divided MCI into early and late 
categories based on neuropsychological performance, where between 1.0 and 1.5 
SD below the norm represents early MCI and more than 1.5 SD below the norm 
represents late MCI [28, 29]. The DSM-5 might tend to apply both early and late 
MCI to mild NCD. Theoretically, below -1.5 SD corresponds to 6.7% of the 
population with a normal distribution and -2.0 – -1.0 SD corresponds to 13.6% of 
the population. Thus, it might be expected to increase the prevalence of MCI. 
However, the change in performance on standardized neuropsychological tests 
from -1.5 SD to -2.0 – -1.0 SD reduced the prevalence of MCI significantly, 
resulting in a decrease in overall prevalence of MCI (Table 11). This may be due to 
the relatively small proportion of cognitive concern (37.2%) from subjects with 
neuropsychological performance between 1.0 SD and 1.5 SD below the norm 
compared with 64.4% and 71.1% from those who are between 2.0 SD and 1.5 SD, 
and those 2.0 SD or lower below the norms, respectively, in the KLOSCAD. The 
other explanation is that the relatively large proportion of subjects with 
neuropsychological performance of 2.0 SD or below the norm had an independent 
functional level in activities of daily living. Those subjects became diagnostic 
orphans because of the discrepancy between the levels of neuropsychological 
performance and functional independence ((A) in Figure 1). In the NaSDEK, using 
1.0 SD below the norm for MCI increased the value of Cohen’s kappa from 0.151 
to 0.273 and it increased the prevalence of MCI from 27.18% to 31.85%, which 
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seems a natural consequence of the inclusion of early MCI without exclusion of 
subjects with neuropsychological performance of -2.0 SD or worse. Exclusion of 
delirium or major psychiatric disorder also decreased the number of subjects with 
MCI in the NaSDEK and KLOSCAD (Table 10), but it did not cause a significant 
decrease in the prevalence estimate (Table 11).  
Since a majority of previous epidemiological studies have been performed 
on subjects with late MCI without the lower limit on neuropsychological 
performance, direct comparisons between the prevalence estimates of MCI and 
mild NCD should be conducted with caution. The prevalence of mild NCD in a 
Spanish elderly population was estimated to be 3.72% [9], which was only about 
one third or fourth of our estimate in a Korean elderly population (11.0% in 
NaSDEK, 15.99% in KLOSCAD). However, this difference may be largely 
attributed to methodological differences between the studies rather than 
geographical differences. For example, the prevalence estimates of MCI increased 
as the number of applied neuropsychological tests for objectively ascertaining the 
presence of cognitive impairment increased [30]. Eleven neuropsychological tests 
were applied in the current study whereas only three tests were applied in the study 
on the Spanish population by Lopez et al. [9].  
 
Diagnostic orphans due to the discrepancy between neurocognitive 
performance and the level of functional independence  
When we apply both criteria for neuropsychological performance and the level of 
functional independence for diagnosing major or mild NCDs, subjects with 
diagnostic orphans become inevitable because the cutoff for diagnosing either 
NCD using neuropsychological performance does not exactly match up with the 
cutoff for the functional level. Subjects with older age and extremely low or high 
educational attainment may raise the probability of discrepancies between 
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objective neuropsychological performance and functional impairment related to 
cognitive decline. It is possible that they may be outliers with respect to the current 
standard norm or their functional impairment may be over- or under-estimated. 
Despite this interpretation, the clinical implication of the diagnostic orphans may 
be the loss of at-risk clinical populations. We found that the diagnostic orphans (A) 
in the KLOSCAD (Figure 1) had a higher conversion rate to major NCD than those 
who were diagnosed with mild NCD, at two-, four-, and six-year follow-ups (Table 
13). After adjusting variables that showed significant differences between 
diagnostic orphans and subjects with mild NCD, diagnostic orphans were 
associated with about a 2.0-fold risk for progression to major NCD at two-, four-, 
and six-year follow-ups.  
To solve the problem of diagnostic orphans, we recommend against 
operating on the lower limit of the typical range of neuropsychological 
performance (-2.0 SD) for diagnosing mild NCD and the upper limit of the typical 
range of neuropsychological performance (-2.0 SD) for diagnosing major NCD. 
Accordingly, diagnostic orphans such as (A) in Figure 1 could be mild NCDs and 
diagnostic orphans such as (B)(A1) in Figure 1 could be major NCDs. We can also 
give hierarchical priority to one of the two criteria for neuropsychological 
performance and functional impairment when a diagnostic orphan occurs. Giving 
priority to the former may increase the prevalence estimate of major NCD and 
giving priority to the latter may minimize the diagnostic discrepancy between 
DSM-IV/IWG-MCI and DSM-5. Depending on the purpose of the diagnosis, the 
application of the priority may be different. 
 
Limitations and Strengths 
This study has several limitations. First, we did not conduct a standardized 
neuropsychological test to ascertain the presence of social cognition impairments 
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because the current study was conducted prior to the release of the DSM-5. This 
may have reduced the diagnostic discrepancy between major/mild NCD and 
dementia/MCI. Second, although we gathered comprehensive and detailed data that 
included history, neurological and physical examinations, comprehensive 
neuropsychological tests, and laboratory and neuroimaging tests using the 
CERAD-K Assessment Battery, NCD diagnoses were made by retrofitting the 
dataset of the NASDEK and KLOSCAD, which was conducted before the release 
of the DSM-5. Third, we did not employ instruments for activities of daily living. 
However, we determined functional impairment by the stringent clinical judgment 
of a research geropsychiatrist, and corroborated the judgment through case 
conferences with four research geropsychiatrists.  
The strengths of the present study were that it was the first study to 
investigate the impact of each changed criterion in the DSM-5 on the prevalence of 
dementia and MCI. Moreover, we investigated the differential impact of each 
changed criterion according to demographic characteristics. Results may have 
generalizability because the same results from two independent representative 
random samples were found despite the differences in the sociodemographic and 
clinical characteristics between the two samples. Finally, it is the first study to 
examine the impact of the introduction of DSM-5 on the prevalence of dementia 
and MCI in an Asian population.  
 
CONCLUSION 
In conclusion, the diagnostic classifications and criteria for major NCD and mild 
NCD in the DSM-5 may result in a decrease in prevalence estimates from 
dementia/MCI to major/mild NCD. The diagnostic discrepancy was modest 
between major NCD and dementia, and was significant between mild NCD and 
MCI. Criterion about performance of standardized neuropsychological testing was 
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significantly attributable to a decrease in the prevalence of MCI. Hierarchical 
application of each criterion may minimize the number of subjects with diagnostic 
orphans who occurred because of a mismatch between neuropsychological 
performance and the level of functional impairment when using DSM-5.  
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S1. Diagnostic criteria for dementia and major neurocognitive disorder (NCD) 
DSM-IV (1994): Dementia DSM-5 (2013): Major NCD 
A. The development of multiple 
cognitive deficits manifested by both: 
1. Memory impairment (impaired 
ability to learn new information or to 
recall previously learned information) 
2. One or more of the following 
cognitive disturbances: 
(a) aphasia (language disturbance) 
(b) apraxia (impaired ability to 
carry out motor 
activities despite intact motor 
function) 
(c) agnosia (failure to recognize or 
identify objects despite intact 
sensory function) 
(d) disturbance in executive 
functioning (i.e., planning, 
organizing, sequencing, 
abstracting)  
B. The cognitive deficits in criteria A1 
and A2 each cause significant 
impairment in social or occupational 
functioning and represent a significant 
decline from a previous level of 
functioning. 
C. The deficits do not occur exclusively 
during the course of a delirium 
A. Evidence of significant cognitive 
decline from a previous level of 
performance in one or more cognitive 
domains (complex attention, executive 
function, learning and memory, 
language, perceptual-motor, or social 
cognition) based on: 
A1. Concern of the individual, a 
knowledgeable informant, or the 
clinician that there has been a 
significant decline in cognitive 
function; and 
A2. A substantial impairment in 
cognitive performance, preferably 
documented by standardized 
neuropsychological testing or, in its 
absence, another quantified clinical 
assessment. 
B. The cognitive deficits interfere with 
independence in everyday activities 
(i.e., at a minimum, requiring 
assistance with complex instrumental 
activities of daily living such as pay 
bills or managing medications). 
C. The cognitive deficits do not occur 
exclusively in the context of a delirium 
The cognitive deficits are not better 
explained by another mental disorders 
(e.g., major depressive disorder, 
schizophrenia) 




S2. Diagnostic criteria for mild cognitive impairment and mild neurocognitive 
disorder (NCD) 
IWG-MCI (2004): Mild cognitive 
impairment 
DSM-5 (2013): Mild NCD 
International working group on MCI (2
004) 
General criteria for MCI 
Not normal, not demented (Dose not m
eet criteria (DSM-IV, ICD-10) for a de
mentia syndrome) 
A. Cognitive decline 
A1. Self and/or informant report and 
impairment on objective cognitive 
tasks and/or 
A2. Evidence of decline over time on 
objective cognitive tasks 
B. Preserved basic activities of daily 
living / minimal in complex 
instrumental functions 
 
Original criteria (1999) for amnestic m
ild cognitive impairment 
1. Memory complaint, preferably 
corroborated by an informant 
2. Impaired memory function for 
age and education 
3. Preserved general cognitive 
function 
4. Intact activities of daily living 
5. Not demented 
 
A. Evidence of modest cognitive 
decline from a previous level of 
performance in one or more cognitive 
domains (complex attention, executive 
function, learning and memory, 
language, perceptual-motor, or social 
cognition) based on 
A1. Concern of the individual, a 
knowledgeable informant, or the 
clinician that there has been a mild 
decline in cognitive function; and 
A2. A modest impairment in 
cognitive performance, preferably 
documented by standardized 
neuropsychological testing or, in its 
absence, another quantified clinical 
assessment. 
B. The cognitive deficits do not 
interfere with capacity for 
independence in everyday activities 
(i.e., complex instrumental activities 
of daily living such as paying bills or 
managing medications are preserved, 
but greater effort, compensatory 
strategies, or accommodation may be 
required). 
C. The cognitive deficits do not occur 
exclusively in the context of a 
delirium. 
 The cognitive deficits are not better 
explained by another mental disorder 
(e.g., major depressive disorder, 
schizophrenia) 
Abbreviations: DSM, Diagnostic and Statistical Manual of Mental Disorders; IWG-MCI, 






서론: 2013년 정신질환 진단 및 통계 편람(Diagnostic and Statistical Manual of 
Mental Disorders) 5판(DSM-5)에서 주요신경인지장애 및 경도신경인지장애의 
진단 기준이 발표되었다. 본 연구에서는 정신질환 진단 및 통계 편람 5판의 
신경인지장애 진단 기준이 치매와 경도인지장애의 유병율에 미치는 영향을 
검증하고자 하였다.  
방법: 두 개의 독립적인 전국단위 노인 표본인 제2차 전국치매역학조사 
(Nationwide Survey on Dementia Epidemiology in Korea; NaSDEK 2012)의 진단 
평가에 참여한 65세 이상 755명, 전국단위 지역사회 전향적 코호트 연구인 
한국인의 인지노화와 치매에 대한 전향적 연구 (Korean Longitudinal Study on 
Cognitive Aging and Dementia; KLOSCAD) 기저평가에 참여한 60세 이상 
6,818명의 평가 자료를 DSM-5 진단 기준에 따라 재진단하였다.  
결과: 2010년 센서스 노인 인구의 연령, 성별, 교육연한, 도농 표준화 
주요신경인지장애 유병율은 8.35%/5.15% (NaSDEK/KLOSCAD) 였고, 
경도신경인지장애 유병율은 11.10%/15.99% 였다. DSM-IV 진단 기준에 따른 
치매 유병율은 8.74%/5.32% 였고, International working group on mild cognitive 
impairment 진단 기준에 따른 경도인지장애 유병율은 27.18%/26.64% 였다. 
주요신경인지장애와 치매의 Cohen’s kappa 값은 0.988/0.969 였으며, 경도신경 
인지장애와 경도인지장애의 Cohen’s kappa 값은 0.151/0.210 으로 나타났다. 
신경인지검사 수행수준에 대한 진단기준 항목이 주요/경도신경인지장애와 
치매/경도인지장애의 진단 불일치의 주된 요인으로 작용하였다. 연령, 성별, 
교육연한 계층별 치매 유병율은 각 계층별 주요신경인지장애 유병율과 유의 
한 차이가 없었으나, 75세 이상, 여성, 교육연한 7년 이상인 층을 제외한 전 
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계층에서 경도신경인지장애 유병율은 경도인지장애 유병율에 비해 유의한 
감소를 보였다. 
결론: DSM-5 진단 기준을 사용할 경우 치매와 주요신경인지장애의 유병율 
수준은 비슷하나, 경도인지장애에 비해 경도신경인지장애의 유병율은 유의 
하게 낮아진다. 신경인지검사 수행수준에 대한 진단기준항목과 일상 생활 기 
능에서의 독립 수준에 대한 진단기준항목 불일치에서 발생하는 진단 상실자 
(diagnostic orphans)를 최소화하기 위하여 진단 기준의 위계적 적용이 도움이 
될 수 있다.   
…………………………………… 
주요어: 유병율, 정신질환 진단 및 통계 편람 5판, 치매, 경도인지장애, 주요  
신경인지장애, 경도신경인지장애, 역학  
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